Antihyperlipidemic, Antihyperglycemic, and Liver Function Protection of <i>Olea europaea</i> var. Meski Stone and Seed Extracts: LC-ESI-HRMS-Based Composition Analysis

<div>Comparative base peak chromatograms of all extracts from major identified metabolites, <i>Olea europaea</i> var. meski organs. (a) Stones (methanol); (b) stones (methanol/H<sub>2</sub>O); (c) seeds (methanol); (d) seeds (methanol/H2O). 2: hydroxytyrosol; 8: oleoside 11-methyl ester; 12: verbascoside; 15: nuzhenide; 17: oleuropein; 19: ligstroside; 24: 9,12,13-trihydroxy octadeca-7-enoic acid; 25: oleuropein aglycon; 26: maslinic acid; 27: hydroxyoctadecadienoic acid; 28: oleanolic acid; 29: eicosanoic acid; 30: dihydroxyheneicosanoic acid.</div>

Journal of Diabetes Research

fig2

Figure 2

Figure 2: Antihyperlipidemic, Antihyperglycemic, and Liver Function Protection of <i>Olea europaea</i> var. Meski Stone and Seed Extracts: LC-ESI-HRMS-Based Composition Analysis 

Figure 2 | Antihyperlipidemic, Antihyperglycemic, and Liver Function Protection of Olea europaea var. Meski Stone and Seed Extracts: LC-ESI-HRMS-Based Composition Analysis 